BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 30176662)

  • 21. Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture.
    Chung A; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; McLeod D; Fanning S; Kariyawasam V; Byth K
    Endoscopy; 2011 Dec; 43(12):1025-32. PubMed ID: 22068701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
    Al Natour RH; Catanzaro A; Zolotarevsky E; DeBenedet AT; Gunaratnam NT
    Dis Esophagus; 2018 Jan; 31(1):1-6. PubMed ID: 29087500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Cryotherapy as a Primary Endoscopic Ablation Modality for Dysplastic Barrett's Esophagus and Early Esophageal Neoplasia: A Systematic Review and Meta-Analysis.
    Tariq R; Enslin S; Hayat M; Kaul V
    Cancer Control; 2020; 27(1):1073274820976668. PubMed ID: 33297725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus: the role of esophagectomy in the era of endoscopic eradication therapy.
    Luna RA; Gilbert E; Hunter JG
    Curr Opin Gastroenterol; 2012 Jul; 28(4):362-9. PubMed ID: 22517568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States.
    Yang D; Coman RM; Kahaleh M; Waxman I; Wang AY; Sethi A; Shah AR; Draganov PV
    Gastrointest Endosc; 2017 Oct; 86(4):600-607. PubMed ID: 27688205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.
    Bahin FF; Jayanna M; Hourigan LF; Lord RV; Whiteman D; Williams SJ; Lee EY; Bourke MJ
    Gastrointest Endosc; 2016 Jan; 83(1):68-77. PubMed ID: 26096759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of recurrence of dysplasia or cancer in patients with dysplastic Barrett's esophagus following complete eradication of dysplasia: a single-center retrospective cohort study.
    Kobayashi R; Calo NC; Marcon N; Iwaya Y; Shimamura Y; Honda H; Streutker C; Mosko J; May G; Teshima C
    Surg Endosc; 2022 Jul; 36(7):5041-5048. PubMed ID: 34750708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic Management of Early Esophageal Cancer.
    Barnes JA; Willingham FF
    J Clin Gastroenterol; 2015 Sep; 49(8):638-46. PubMed ID: 26125458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
    Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
    Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic versus surgical therapy for Barrett's esophagus neoplasia.
    Smith I; Kahaleh M
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):31-5. PubMed ID: 25160753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.
    Belghazi K; Bergman JJGHM; Pouw RE
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):461-470. PubMed ID: 28577767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer.
    Rajaram R; Hofstetter WL
    Thorac Surg Clin; 2018 Nov; 28(4):473-480. PubMed ID: 30268293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):370-9. PubMed ID: 18494132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges.
    Pech O
    Adv Exp Med Biol; 2016; 908():99-109. PubMed ID: 27573769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
    DeMeester SR
    Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
    [No Abstract]   [Full Text] [Related]  

  • 39. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Krishnadath KK; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):359-69. PubMed ID: 18494131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.
    Reed CC; Shaheen NJ
    J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):768-772. PubMed ID: 27541732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.